Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H1 2013'', provides a
|
$ 2000
|
|
|
Bladder Cancer – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Bladder Cancer - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic developme
|
$ 2000
|
|
|
Bladder Cancer – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Bladder Cancer - Pipeline Review, H2 2012'', provides an overview of the Bladder Cancer therapeutic pipeline. This report provides information on the therapeutic develop
|
$ 2000
|
|
|
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2012'', provides a
|
$ 2000
|
|
|
China's demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environmen...
|
$ 4000
|
|
|
GlobalData’s pharmaceuticals report, provides Iressa global sales estimates. In addition, it covers detaile
|
$ 2000
|
|
|
GlobalData’s pharmaceuticals report, provides Ellence EU sales estimates. In addition, it covers detail
|
$ 2000
|
|
|
GlobalData’s pharmaceuticals report, provides Tykerb global sales estimates. In addition, it covers detai
|
$ 2000
|
|
|
GlobalData’s pharmaceuticals report, provides Eoquin global sales estimates. In addition, it covers detai
|
$ 2000
|
|
|
GlobalData’s pharmaceuticals report, provides Javlor global sales estimates. In addition, it covers detai
|
$ 2000
|
|
|
GlobalData’s pharmaceuticals report, provides Javlor global sales estimates. In addition, it covers
|
$ 2000
|
|
|
GlobalData’s pharmaceuticals report, provides MVAC global sales estimates. In addition, it covers detailed cl
|
$ 2000
|
|
|
GlobalData’s pharmaceuticals report, provides BCG global sales estimates. In addition, it covers detailed clini
|
$ 2000
|
|
|
GlobalData’s pharmaceuticals report, provides Gemzar global sales estimates. In addition, it covers detai
|
$ 2000
|
|
|
GlobalData’s pharmaceuticals report, provides Thiotepa global sales estimates. In addition, it covers
|
$ 2000
|
|
|
GlobalData’s pharmaceuticals report, provides Urocidin global sales estimates. In addition, it covers
|
$ 2000
|
|
|
GlobalData’s pharmaceuticals report, provides Valstar global sales estimates. In addition, it covers de
|
$ 2000
|
|
|
GlobalData, the industry analysis specialist, has released its new report, Bladder Cancer - Global Drug Forecasts and Treatment Analysis t...
|
$ 5000
|
|
|
GlobalData, the industry analysis specialist, has released its new report, “”. The report...
|
$ 2000
|
|
|
Life Science Analytics', Bladder Cancer Therapy Area Pipeline Report contains detailed information on the bladder cancer drug pipeline. This report provides insight into the pipeline status of bladder canc...
|
$ 1511
|
|
|